JNJ
185.83
-0.68%↓
ABT
124.99
-1.16%↓
TMO
568.97
+1.87%↑
ISRG
539.52
-0.56%↓
DHR
218.13
-0.03%↓
JNJ
185.83
-0.68%↓
ABT
124.99
-1.16%↓
TMO
568.97
+1.87%↑
ISRG
539.52
-0.56%↓
DHR
218.13
-0.03%↓
JNJ
185.83
-0.68%↓
ABT
124.99
-1.16%↓
TMO
568.97
+1.87%↑
ISRG
539.52
-0.56%↓
DHR
218.13
-0.03%↓
JNJ
185.83
-0.68%↓
ABT
124.99
-1.16%↓
TMO
568.97
+1.87%↑
ISRG
539.52
-0.56%↓
DHR
218.13
-0.03%↓
JNJ
185.83
-0.68%↓
ABT
124.99
-1.16%↓
TMO
568.97
+1.87%↑
ISRG
539.52
-0.56%↓
DHR
218.13
-0.03%↓
24h
Current
Min
3.74
Max
3.93
Income | 3.7M -4.5M |
|---|---|
Sales | -1.8M 492K |
Profit margin | -913.618 |
Employees | 32 |
EBITDA | 1.2M -3.6M |
Recommendations | Neutral |
|---|---|
12 Months Forecast | +1053.85% upside |
Next Earnings | 11 Nov 2025 |
|---|
Market Cap | 21M |
|---|---|
Previous open | 1.17 |
Previous close | 3.84 |
By Trading Central
Confidence
Neutral Evidence
0.8417 / 0.8939 Support & Resistance
Past performance is not a reliable indicator of future results.
28 Oct 2025, 23:50 UTC
Stocks to Watch: Caesars, Enphase, Mondelez, Teradyne
DJ
Read
28 Oct 2025, 23:25 UTC
SK Hynix Posts Record Earnings on Continued AI-Chip Demand
DJ
Read
28 Oct 2025, 23:18 UTC
Booking 3Q Sales Rise as U.S. Travel Demand Stabilizes -- Update
DJ
Read
28 Oct 2025, 22:20 UTC
Visa Sales Jump as Consumers Keep Spending -- 2nd Update
DJ
Read
28 Oct 2025, 22:13 UTC
Wal-Mart de Mexico Net Profit Falls in 3Q
DJ
Read
28 Oct 2025, 21:38 UTC
Correction to Visa Sales Jump Article
DJ
Read
28 Oct 2025, 21:17 UTC
OrthoPediatrics Wins FDA Approval for Surgery Plating System; 3Q Revenue Rises
DJ
Read
28 Oct 2025, 21:07 UTC
Visa Sales Jump as Consumers Keep Spending -- Update
DJ
Read
28 Oct 2025, 21:02 UTC
Mondelez Tempers Outlook as Costs Rise
DJ
Read
28 Oct 2025, 23:51 UTC
Nikkei May Rise on Easing U.S.-China Tensions -- Market Talk
DJ
Read
28 Oct 2025, 23:42 UTC
Gold Edges Lower on Possible Position Adjustments Ahead of FOMC Decision -- Market Talk
DJ
Read
28 Oct 2025, 23:02 UTC
SK Hynix: HBM4 Shipments to Start in 4Q, Ahead of Full-Scale Sales Expansion in 2026
DJ
Read
28 Oct 2025, 23:01 UTC
SK Hynix: Completed Discussions With Key Customers About 2026 HMB Supply
DJ
Read
28 Oct 2025, 22:46 UTC
SK Hynix: Co. Secured Full Customer Demand for Its Entire DRAM and NAND Production for Next Yr >000660.SE
DJ
Read
28 Oct 2025, 22:45 UTC
SK Hynix 3Q Net KRW12.6T >000660.SE
DJ
Read
28 Oct 2025, 22:44 UTC
SK Hynix 3Q Rev KRW24.44T >000660.SE
DJ
Read
28 Oct 2025, 22:43 UTC
SK Hynix 3Q Net Profit Beat FactSet-Compiled Consensus
DJ
Read
28 Oct 2025, 22:42 UTC
SK Hynix 3Q Net KRW12.598T Vs. Net KRW5.753T >000660.SE
DJ
Read
28 Oct 2025, 22:40 UTC
SK Hynix 3Q Rev KRW24.449T Vs. KRW17.573T >000660.SE
DJ
Read
28 Oct 2025, 22:40 UTC
SK Hynix 3Q Oper Pft KRW11.383T Vs. Pft KRW7.030T >000660.SE
DJ
Read
28 Oct 2025, 22:22 UTC
Pharmaron Beijing: Higher Contributions From Clinical-Development Services Supported Results >300759.SZ
DJ
Read
28 Oct 2025, 22:22 UTC
Pharmaron Beijing: Higher Contributions From Laboratory Services Supported Results >300759.SZ
DJ
Read
28 Oct 2025, 22:22 UTC
Pharmaron Beijing 3Q Net CNY439.52M, Up 42.5% on Year >300759.SZ
DJ
Read
28 Oct 2025, 22:20 UTC
Pharmaron Beijing 3Q Rev CNY3.64B, Up 13.4% on Year >300759.SZ
DJ
Read
28 Oct 2025, 22:02 UTC
Review & Preview: Earnings Extravaganza -- Barrons.com
DJ
Read
28 Oct 2025, 21:42 UTC
Global Equities Roundup: Market Talk
DJ
Read
28 Oct 2025, 21:42 UTC
Mondelez Says Cocoa Costs Peaked Heading Into Spooky Season -- Market Talk
DJ
Read
28 Oct 2025, 21:20 UTC
Wal-Mart de Mexico 3Q EBITDA MXN25.27B, Up 3.3% on Year
DJ
Read
28 Oct 2025, 21:19 UTC
Wal-Mart de Mexico 3Q Rev MXN241.52B, Up 4.9% on Year
DJ
Read
28 Oct 2025, 21:18 UTC
Wal-Mart de Mexico 3Q Net MXN11.75B, Down 9.2% on Year
DJ
Read
Price change
By TipRanks
12 Months Forecast
Average 45 USD 1053.85%
High 45 USD
Low 45 USD
Based on 2 Wall Street analysts offering 12 month price targets forClearside Biomedical Inc - Dist in the last 3 months.
By TipRanks
Neutral
2 ratings
0
Buy
2
Hold
0
Sell
Based on 2 analysts giving stock ratings to Clearside Biomedical Inc - Dist in the past 3 months.
By Trading Central
Short Term
Neutral Evidence
The bullish and bearish events are balanced.
Intermediate Term
Strong Bearish Evidence
Recent bearish events outweigh bullish events.
Long Term
Weak Bearish Evidence
There is one bearish event.
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$